Tennessee SB 2037: Drugs, Prescription - As introduced, requires a practitioner to discuss with a patient the risks associated with a Schedule II controlled, dangerous substance or other opioid pain reliever prior to the initial prescription and prior to the third prescription. - Amends TCA Title 39; Title 40; Title 53; Title 63 and Title 68.

Status: Failed in s/c Health Subcommittee of Health Committee (as of 2022-03-22)

State: Tennessee · Session: 112 · Bill: SB 2037

Subjects: Drugs, Prescription

Sponsors: Gilmore, Harris

View Tennessee SB 2037 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.